Search research articles
Contact Us
Filters
Showing results (111-120 of 204) with videos related to
Page
of 21
Sort By:
Gynecologic Oncology
|
September 18, 2016
Electronic patient-reported outcomes from home in patients recovering from major gynecologic cancer surgery: A prospective study measuring symptoms and health-related quality of life
Renee A Cowan, Rudy S Suidan, Vaagn Andikyan, et al.
Gynecologic Oncology
|
December 14, 2011
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer
Joyce N Barlin, Changhong Yu, Emily K Hill, et al.
Annals of Surgical Oncology
|
May 4, 2026
Predictive Value of Routine Imaging for the Diagnosis of Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
Maria Müller, Jörg Heil, André Pfob, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 11, 2022
Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series
Tiffany Y Sia, Beryl Manning-Geist, Sushmita Gordhandas, et al.
JMIR Cancer
|
November 18, 2021
Digital Technical and Informal Resources of Breast Cancer Patients From 2012 to 2020: Questionnaire-Based Longitudinal Trend Study
Christoph A Mallmann, Christian M Domröse, Lars Schröder, et al.
Gynecologic Oncology
|
May 13, 2019
Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center
Olga T Filippova, Dennis S Chi, Kara Long Roche, et al.
Cancer
|
March 23, 2023
Chemotherapy response in low-grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies
Beryl L Manning-Geist, Ryan M Kahn, David Nemirovsky, et al.
Gynecologic Oncology
|
February 28, 2017
Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?
Vasileios D Sioulas, Maria B Schiavone, David Kadouri, et al.
Gynecologic Oncology
|
August 22, 2018
Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?
Jill H Tseng, Renee A Cowan, Qin Zhou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 12, 2020
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer
Ying L Liu, Qin C Zhou, Alexia Iasonos, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 204) with videos related to
Sort By:
Page
of 21
Gynecologic Oncology
|
September 18, 2016
Electronic patient-reported outcomes from home in patients recovering from major gynecologic cancer surgery: A prospective study measuring symptoms and health-related quality of life
Renee A Cowan, Rudy S Suidan, Vaagn Andikyan, et al.
Gynecologic Oncology
|
December 14, 2011
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer
Joyce N Barlin, Changhong Yu, Emily K Hill, et al.
Annals of Surgical Oncology
|
May 4, 2026
Predictive Value of Routine Imaging for the Diagnosis of Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
Maria Müller, Jörg Heil, André Pfob, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 11, 2022
Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series
Tiffany Y Sia, Beryl Manning-Geist, Sushmita Gordhandas, et al.
JMIR Cancer
|
November 18, 2021
Digital Technical and Informal Resources of Breast Cancer Patients From 2012 to 2020: Questionnaire-Based Longitudinal Trend Study
Christoph A Mallmann, Christian M Domröse, Lars Schröder, et al.
Gynecologic Oncology
|
May 13, 2019
Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center
Olga T Filippova, Dennis S Chi, Kara Long Roche, et al.
Cancer
|
March 23, 2023
Chemotherapy response in low-grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies
Beryl L Manning-Geist, Ryan M Kahn, David Nemirovsky, et al.
Gynecologic Oncology
|
February 28, 2017
Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?
Vasileios D Sioulas, Maria B Schiavone, David Kadouri, et al.
Gynecologic Oncology
|
August 22, 2018
Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?
Jill H Tseng, Renee A Cowan, Qin Zhou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 12, 2020
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer
Ying L Liu, Qin C Zhou, Alexia Iasonos, et al.
Page
of 21